Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

162 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The Role of mpMRI in the Assessment of Prostate Cancer Recurrence Using the PI-RR System: Diagnostic Accuracy and Interobserver Agreement in Readers with Different Expertise.
Bergaglio C, Giasotto V, Marcenaro M, Barra S, Turazzi M, Bauckneht M, Casaleggio A, Sciabà F, Terrone C, Mantica G, Borghesi M, Signori A, Spina B, Piol N, Zanardi E, Fornarini G, Zawaideh JP; Uro-Oncology Disease Management Team (DMT) of the IRCCS Ospedale Policlinico San Martino Genoa, Italy. Bergaglio C, et al. Among authors: zanardi e. Diagnostics (Basel). 2023 Jan 20;13(3):387. doi: 10.3390/diagnostics13030387. Diagnostics (Basel). 2023. PMID: 36766492 Free PMC article.
Advanced soft-tissue sarcoma in elderly patients: patterns of care and survival.
Garbay D, Maki RG, Blay JY, Isambert N, Piperno Neumann S, Blay C, Zanardi E, Boudou-Rouquette P, Bozec L, Duffaud F, Bertucci F, Italiano A. Garbay D, et al. Among authors: zanardi e. Ann Oncol. 2013 Jul;24(7):1924-1930. doi: 10.1093/annonc/mdt059. Epub 2013 Mar 13. Ann Oncol. 2013. PMID: 23493135 Free article.
Impaired response to influenza vaccine associated with persistent memory B cell depletion in non-Hodgkin's lymphoma patients treated with rituximab-containing regimens.
Bedognetti D, Zoppoli G, Massucco C, Zanardi E, Zupo S, Bruzzone A, Sertoli MR, Balleari E, Racchi O, Messina M, Caltabiano G, Icardi G, Durando P, Marincola FM, Boccardo F, Ferrarini M, Ansaldi F, De Maria A. Bedognetti D, et al. Among authors: zanardi e. J Immunol. 2011 May 15;186(10):6044-55. doi: 10.4049/jimmunol.1004095. Epub 2011 Apr 15. J Immunol. 2011. PMID: 21498665 Free PMC article.
A Case of Plasmacytoid Variant of Bladder Cancer With a Single Penile Metastasis and a Complete Response to Carboplatin-Based Chemotherapy and Review of the Literature.
Messina C, Zanardi E, Dellepiane C, Tomasello L, Colecchia M, Ravetti GL, Boccardo F, Spina B. Messina C, et al. Among authors: zanardi e. Clin Genitourin Cancer. 2016 Feb;14(1):e139-42. doi: 10.1016/j.clgc.2015.10.012. Epub 2015 Oct 28. Clin Genitourin Cancer. 2016. PMID: 26627132 Review. No abstract available.
Role of Baseline and Post-Therapy 18F-FDG PET in the Prognostic Stratification of Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients Treated with Radium-223.
Bauckneht M, Capitanio S, Donegani MI, Zanardi E, Miceli A, Murialdo R, Raffa S, Tomasello L, Vitti M, Cavo A, Catalano F, Mencoboni M, Ceppi M, Marini C, Fornarini G, Boccardo F, Sambuceti G, Morbelli S. Bauckneht M, et al. Among authors: zanardi e. Cancers (Basel). 2019 Dec 20;12(1):31. doi: 10.3390/cancers12010031. Cancers (Basel). 2019. PMID: 31861942 Free PMC article.
Opportunistic skeletal muscle metrics as prognostic tools in metastatic castration-resistant prostate cancer patients candidates to receive Radium-223.
Bauckneht M, Lai R, D'Amico F, Miceli A, Donegani MI, Campi C, Schenone D, Raffa S, Chiola S, Lanfranchi F, Rebuzzi SE, Zanardi E, Cremante M, Marini C, Fornarini G, Morbelli S, Piana M, Sambuceti G. Bauckneht M, et al. Among authors: zanardi e. Ann Nucl Med. 2022 Apr;36(4):373-383. doi: 10.1007/s12149-022-01716-w. Epub 2022 Jan 19. Ann Nucl Med. 2022. PMID: 35044592 Free PMC article.
Immune Checkpoint Inhibitors in Advanced Prostate Cancer: Current Data and Future Perspectives.
Rebuzzi SE, Rescigno P, Catalano F, Mollica V, Vogl UM, Marandino L, Massari F, Pereira Mestre R, Zanardi E, Signori A, Buti S, Bauckneht M, Gillessen S, Banna GL, Fornarini G. Rebuzzi SE, et al. Among authors: zanardi e. Cancers (Basel). 2022 Feb 28;14(5):1245. doi: 10.3390/cancers14051245. Cancers (Basel). 2022. PMID: 35267553 Free PMC article. Review.
Beyond the Prognostic Value of 2-[18F]FDG PET/CT in Prostate Cancer: A Case Series and Literature Review Focusing on the Diagnostic Value and Impact on Patient Management.
Borea R, Favero D, Miceli A, Donegani MI, Raffa S, Gandini A, Cremante M, Marini C, Sambuceti G, Zanardi E, Morbelli S, Fornarini G, Rebuzzi SE, Bauckneht M. Borea R, et al. Among authors: zanardi e. Diagnostics (Basel). 2022 Feb 24;12(3):581. doi: 10.3390/diagnostics12030581. Diagnostics (Basel). 2022. PMID: 35328134 Free PMC article. Review.
162 results